Efficacy and Safety of Once-Weekly Semaglutide vs. Sitagliptin as Add-on to Metformin and/or Thiazolidinediones after 56 Weeks in Subjects with Type 2 Diabetes (SUSTAIN 2)

Ahren B., Comas L. M. , Kumar H., Sargin M., Karsbol J. D. , Jacobsen S. H. , ...More

76th Scientific Sessions of the American-Diabetes-Association, Louisiana, United States Of America, 10 - 14 June 2016, vol.65 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 65
  • City: Louisiana
  • Country: United States Of America